Skip to main content
OpenTrials
Completed

NCT Number: NCT00748800

An Affect Management Intervention for Juvenile Offenders

Adolescents are at risk for HIV because of sexual and drug behavior initiated during this developmental period. Adolescents in the juvenile justice system are at increased risk for HIV due to higher rates of substance use and psychopathology than their non-offending peers. Juvenile justice youth may therefore also be less likely to benefit from frequently used skills based interventions. It appears that emotional lability, frequently found in this population, disrupts skills learned. This project will implement and evaluate an affect management HIV prevention intervention for adolescents in a juvenile drug court program. Affect management and general health promotion interventions will be compared to determine which intervention best reduces risk behavior among adolescents in the drug court.

Completed

Looking for future studies?

Notify Me

Key information

Age range

13 year–18 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Primary location

Rhode Island Hospital

Providence, Rhode Island, 02903, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adolescents enrolled in the juvenile drug court program

Exclusion criteria

  • Adolescent is HIV positive
  • Adolescent is pregnant
  • Adolescent is developmentally delayed
  • Adolescent has history of sexual crime

Treatment and study plan

Affect Management

Behavioral

5 session group intervention that focused on teaching affect management skills and included HIV prevention and sexual health training

General Health Promotion

Behavioral

5 session group focused on delivering general health promotion information in didactic format

Primary outcomes

  1. Adolescent-reported sexual activity and condom use

    Time frame: 3 month post-intervention

Secondary outcomes

  1. Adolescent substance use (self-report and urine toxicology screen results)

    Time frame: 3 months post-intervention

Sponsors and collaborators

Lead sponsor

Rhode Island Hospital

Other

Registry information

Important dates

Study start
2004
Primary completion
2007
Study completion
2007
First posted
Sep 9, 2008
Registry last updated
Feb 6, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.